9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2020
- PMID: 31862752
- DOI: 10.2337/dc20-S009
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2020
Erratum in
-
Addendum. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2020. Diabetes Care 2020;43(Suppl. 1):S98-S110.Diabetes Care. 2020 Aug;43(8):1979. doi: 10.2337/dc20-ad08a. Epub 2020 Jun 5. Diabetes Care. 2020. PMID: 32503835 No abstract available.
Abstract
The American Diabetes Association (ADA) "Standards of Medical Care in Diabetes" includes the ADA's current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee (https://doi.org/10.2337/dc20-SPPC), are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA's clinical practice recommendations, please refer to the Standards of Care Introduction (https://doi.org/10.2337/dc20-SINT). Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.
© 2019 by the American Diabetes Association.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials